MegaFill
“Allogeneic dermis” has a long history of being used in burn dressings or dermal transplantation. Advanced countries in Europe and the United States have begun to develop this technology more than 20 years ago, using allogeneic dermis as an autologous skin transplantation substitute for burns, and has well overcome the previous burn healing process caused by tissue rejection. Significant shortcomings such as scars and contractions.
Produced by L&C Bio, a major medical material manufacturer in South Korea, L&C Bio has been focusing on the field of dermis and human tissue transplantation since its establishment in 2011. After many years of research and development, it has become the chief indicator in Asia, and has a variety of international specialties such as decellular dermal cross-linking technology, dental materials and biological transplantation.
Li,Due to the stable process and excellent quality, it is not only widely used by major medical institutions in South Korea, but also has a leading position in the global medical materials market.
1. High safety: professional processing and sterilization methods, different body dermis already exists in the body, reducing rejection, is a safe and qualified medical product.
2. High compatibility: Heterogeneic dermis has high compatibility with human tissues, eliminating the nucleus and immune-remission factors in the tissue, which is not prone to inflammatory reactions.
3. Accurate application: It is suitable for filling each part. Whether it is shaping or filling, it can have a good effect, and the texture particles are delicate, reducing the formation of nodules, concave and convex inequality. There is no recovery period for needlehole injection, and the care of wounds is very simple and will not affect daily life.
4. Strong support: allogeneic dermal powder is taken from real tissue and transformed. Its material is soft and natural, and it has a high degree of toughness. Compared with other injections, it has better support and stability.
5. Semi-permanent: After the allogeneic dermal powder is compatible with human tissue, depending on the individual’s constitution, about 70-80% of the volume capacity can survive smoothly and remain like its own dermis, so it can achieve a semi-permanent maintenance effec.
The first application is mainly to stabilize the overall tissue. At the same time, observe the survival status of “allogeneic dermal powder”. After a week to 1 month of observation and recovery period, the second application is carried out, which can make the bond between allogeneic dermal powder and the connective tissue more stable.
If the legal tattoo is more serious, it can be supplemented for the third time to achieve a significant and semi-permanent maintenance effect.
點擊按鈕加入各分店LINE好友